Satoshi Deyama

1.8k total citations
57 papers, 1.4k citations indexed

About

Satoshi Deyama is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Biological Psychiatry. According to data from OpenAlex, Satoshi Deyama has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cellular and Molecular Neuroscience, 20 papers in Pharmacology and 16 papers in Biological Psychiatry. Recurrent topics in Satoshi Deyama's work include Neurotransmitter Receptor Influence on Behavior (22 papers), Neuroscience and Neuropharmacology Research (17 papers) and Tryptophan and brain disorders (16 papers). Satoshi Deyama is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (22 papers), Neuroscience and Neuropharmacology Research (17 papers) and Tryptophan and brain disorders (16 papers). Satoshi Deyama collaborates with scholars based in Japan, United States and New Zealand. Satoshi Deyama's co-authors include Ronald S. Duman, Manoela V. Fogaça, Masabumi Minami, Katsuyuki Kaneda, T. KATO, Shuji Kaneko, Soichiro Ide, Masamichi Satoh, Xiaoyuan Li and Takayuki Nakagawa and has published in prestigious journals such as Journal of Neuroscience, American Journal of Psychiatry and Scientific Reports.

In The Last Decade

Satoshi Deyama

54 papers receiving 1.4k citations

Peers

Satoshi Deyama
Caroline A. Stewart United Kingdom
Michal Bajo United States
Sean C. Piantadosi United States
Sung Woo Park South Korea
Elisa S. Na United States
Satoshi Deyama
Citations per year, relative to Satoshi Deyama Satoshi Deyama (= 1×) peers Giulia Treccani

Countries citing papers authored by Satoshi Deyama

Since Specialization
Citations

This map shows the geographic impact of Satoshi Deyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Deyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Deyama more than expected).

Fields of papers citing papers by Satoshi Deyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Deyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Deyama. The network helps show where Satoshi Deyama may publish in the future.

Co-authorship network of co-authors of Satoshi Deyama

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Deyama. A scholar is included among the top collaborators of Satoshi Deyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Deyama. Satoshi Deyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deyama, Satoshi, et al.. (2025). Preventive and Therapeutic Effects of Intracerebroventricular Administration of Maresin-1 on Lipopolysaccharide-Induced Depression-Like Behaviors in Mice. Biological and Pharmaceutical Bulletin. 48(1). 6–10. 1 indexed citations
3.
Nishitani, Naoya, et al.. (2025). Medial prefrontal cortex inputs to the dorsomedial striatum regulate motivation for wheel running in male mice. Journal of Pharmacological Sciences. 159(1). 1–7.
4.
Nishikawa, Keisuke, et al.. (2024). Role of medial prefrontal cortex voltage-dependent potassium 4.3 channels in nicotine-induced enhancement of object recognition memory in male mice. European Journal of Pharmacology. 978. 176790–176790. 2 indexed citations
5.
Deyama, Satoshi, et al.. (2024). Neohesperidin exerts antidepressant-like effect via the mechanistic target of rapamycin complex 1 in the medial prefrontal cortex in male mice. Journal of Pharmacological Sciences. 156(2). 82–85. 1 indexed citations
6.
Deyama, Satoshi, et al.. (2024). Resolvin E1 as a potential lead for the treatment of depression. Folia Pharmacologica Japonica. 159(4). 210–213. 2 indexed citations
8.
9.
Deyama, Satoshi, et al.. (2023). Varenicline enhances recognition memory via α7 nicotinic acetylcholine receptors in the medial prefrontal cortex in male mice. Neuropharmacology. 239. 109672–109672. 9 indexed citations
10.
Deyama, Satoshi, Xiaoyuan Li, & Ronald S. Duman. (2023). Neuron‐specific deletion of VEGF or its receptor Flk‐1 occludes the antidepressant‐like effects of desipramine and fluoxetine in mice. Neuropsychopharmacology Reports. 44(1). 246–249. 3 indexed citations
11.
Saito, Atsushi, et al.. (2023). Social defeat stress enhances the rewarding effects of cocaine through α1A adrenoceptors in the medial prefrontal cortex of mice. Neuropharmacology. 242. 109757–109757. 6 indexed citations
13.
Deyama, Satoshi, Masabumi Minami, & Katsuyuki Kaneda. (2021). Resolvins as potential candidates for the treatment of major depressive disorder. Journal of Pharmacological Sciences. 147(1). 33–39. 14 indexed citations
14.
Deyama, Satoshi & Katsuyuki Kaneda. (2020). The duration of the antidepressant-like effects of a single infusion of brain-derived neurotrophic factor into the medial prefrontal cortex in mice. Behavioural Brain Research. 394. 112844–112844. 16 indexed citations
15.
Deyama, Satoshi & Ronald S. Duman. (2019). Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine. Pharmacology Biochemistry and Behavior. 188. 172837–172837. 137 indexed citations
16.
Deyama, Satoshi, et al.. (2018). Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice. Journal of Pharmacological Sciences. 138(1). 86–88. 39 indexed citations
17.
Ishikawa, Yuka, et al.. (2017). Rapid and sustained antidepressant effects of resolvin D1 and D2 in a chronic unpredictable stress model. Behavioural Brain Research. 332. 233–236. 44 indexed citations
18.
Deyama, Satoshi, et al.. (2017). Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway. The International Journal of Neuropsychopharmacology. 20(7). 575–584. 86 indexed citations
19.
Deyama, Satoshi, Takahiro Katayama, Atsushi Ohno, et al.. (2008). Activation of the β-Adrenoceptor–Protein Kinase A Signaling Pathway within the Ventral Bed Nucleus of the Stria Terminalis Mediates the Negative Affective Component of Pain in Rats. Journal of Neuroscience. 28(31). 7728–7736. 63 indexed citations
20.
Deyama, Satoshi, Takayuki Nakagawa, Shuji Kaneko, Takashi Uehara, & Masabumi Minami. (2006). Involvement of the bed nucleus of the stria terminalis in the negative affective component of visceral and somatic pain in rats. Behavioural Brain Research. 176(2). 367–371. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026